Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis.
Rüfer A, Nilius H, Hermine O, Niedoszytko M, Oude Elberink JNG, Bonadonna P, Shoumariyeh K, Gulen T, Hartmann K, Sabato V, Angelova-Fischer I, Baffoe D, Christen D, Belloni Fortina A, Breynaert C, Brockow K, von Bubnoff N, Bumbea H, van Daele P, Doubek M, Dybedal I, Elena C, Fokoloros C, Górska A, Heizmann M, Jentzsch M, Klein S, Lübke J, Mattsson M, Mulder A, Panse J, Schug TD, Sciumè M, Stefan A, Sztormowska M, Várkonyi J, Wortmann F, Yavuz AS, Sperr M, Gotlib J, Reiter A, Triggiani M, Sperr WR, Valent P.
Rüfer A, et al. Among authors: hartmann k.
Leukemia. 2025 Jan 15. doi: 10.1038/s41375-024-02504-3. Online ahead of print.
Leukemia. 2025.
PMID: 39815050